Results
|
5761.
|
|
|
5762.
|
|
|
5763.
|
YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models. [electronic resource] by
- Xu, Youzhi
- Lin, Hongjun
- Meng, Nana
- Lu, Wenjie
- Li, Guobo
- Han, Yuanyuan
- Dai, Xiaoyun
- Xia, Yong
- Song, Xiangrong
- Yang, Shengyong
- Wei, Yuquan
- Yu, Luoting
- Zhao, Yinglan
Producer: 20140124
In:
British journal of pharmacology vol. 169
Availability: No items available.
|
|
5764.
|
|
|
5765.
|
|
|
5766.
|
|
|
5767.
|
Antitumor activity of sorafenib in FLT3-driven leukemic cells. [electronic resource] by
- Auclair, D
- Miller, D
- Yatsula, V
- Pickett, W
- Carter, C
- Chang, Y
- Zhang, X
- Wilkie, D
- Burd, A
- Shi, H
- Rocks, S
- Gedrich, R
- Abriola, L
- Vasavada, H
- Lynch, M
- Dumas, J
- Trail, P A
- Wilhelm, S M
Producer: 20070413
In:
Leukemia vol. 21
Availability: No items available.
|
|
5768.
|
|
|
5769.
|
|
|
5770.
|
|
|
5771.
|
|
|
5772.
|
The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells. [electronic resource] by
- Niessner, Heike
- Beck, Daniela
- Sinnberg, Tobias
- Lasithiotakis, Konstantinos
- Maczey, Evelyn
- Gogel, Jeannette
- Venturelli, Sascha
- Berger, Alexander
- Mauthe, Mario
- Toulany, Mahmoud
- Flaherty, Keith
- Schaller, Martin
- Schadendorf, Dirk
- Proikas-Cezanne, Tassula
- Schittek, Birgit
- Garbe, Claus
- Kulms, Dagmar
- Meier, Friedegund
Producer: 20110310
In:
The Journal of investigative dermatology vol. 131
Availability: No items available.
|
|
5773.
|
Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3. [electronic resource] by
- Walz, Christoph
- Erben, Philipp
- Ritter, Michael
- Bloor, Adrian
- Metzgeroth, Georgia
- Telford, Nick
- Haferlach, Claudia
- Haferlach, Torsten
- Gesk, Stefan
- Score, Joannah
- Hofmann, Wolf-Karsten
- Hochhaus, Andreas
- Cross, Nicholas C P
- Reiter, Andreas
Producer: 20111024
In:
Blood vol. 118
Availability: No items available.
|
|
5774.
|
|
|
5775.
|
|
|
5776.
|
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro. [electronic resource] by
- Koh, Yoon Woo
- Shah, Manisha H
- Agarwal, Kitty
- McCarty, Samantha K
- Koo, Bon Seok
- Brendel, Victoria J
- Wang, Chaojie
- Porter, Kyle
- Jarjoura, David
- Saji, Motoyasu
- Ringel, Matthew D
Producer: 20120501
In:
Endocrine-related cancer vol. 19
Availability: No items available.
|
|
5777.
|
|
|
5778.
|
Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1. [electronic resource] by
- Huber, S
- Oelsner, M
- Decker, T
- zum Büschenfelde, C Meyer
- Wagner, M
- Lutzny, G
- Kuhnt, T
- Schmidt, B
- Oostendorp, R A J
- Peschel, C
- Ringshausen, I
Producer: 20110809
In:
Leukemia vol. 25
Availability: No items available.
|
|
5779.
|
|
|
5780.
|
|